Stem cell, drug discovery, and analytical services
All services
Clinical Stem Cell Services
Preclinical & Drug Discovery CRO
Human Tissue Samples
Cells and products for stem cell research and 3D cell culture
Featured products
All products
Our product catalog covers the territories of REPROCELL USA (Americas), REPROCELL Europe (EMEA), and Bioserve India.
Stem Cell Reagents
Cells
Stem Cell Products
3D Cell Culture
Labware
Learning resources and technical support online
All learning resources
The REPROCELL Blog
More on the blog
From StemRNA™ Clinical Seed Clone to GMP-Ready Cell Therapy Programs
27 February 2026
Preserving the Microenvironment-Advances in Ex Vivo Colonic Tissue Culture for IBD Drug Discovery
26 February 2026
Latest Webinars
More webinars
Webinar: Innovative Cell Technologies to Bioengineer Human Tissues In Vitro for Use in R&D and Modelling Human Disease
Webinar: Raising the Standard: High-Quality and Reproducible Growth Factors for Advanced Cell Systems
Dr. Luana FerrarQkine
Upcoming Webinars
REPROCELL is all about improving human health through biomedical innovation and discovery
REPROCELL Brands
Upcoming Conferences
More upcoming events
ELRIG Cell and Gene Therapy
9-10 March 2026
IMMUNOLOGY 2026
16-18th April 2026
American Association for Cancer Research - Annual Meeting
17-22 April 2026
Corporate News
More corporate news
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
3 March 2026
REPROCELL Expands Product Portfolio with Addition of BioThrust™ ComfyCell Incu Bioreactor Platform
2 March 2026
Information for investors
Make an inquiry
Connect with our expert scientists and sales teams worldwide. We will figure out who's best to reply to you.
Contact us other ways
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)
Investor Relations